Dina Jacobs, MD
Enriched profileProfessor of Neurology at the Hospital of the University of Pennsylvania · University of Pennsylvania
Dina Jacobs is Professor of Neurology at the Hospital of the University of Pennsylvania at University of Pennsylvania. OpenAlex indexes 77 publications with 4,855 citations (h-index 30); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Dina Jacobs, MD, is Professor of Neurology at the Hospital of the University of Pennsylvania. The public record shows 77 publications with 4,855 citations (h-index 30), centered on Multiple Sclerosis Research Studies, Pregnancy and Medication Impact, Drug-Induced Ocular Toxicity. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 21 companies.
- Top research focus: Multiple Sclerosis Research Studies
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 21 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 40.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis
Sponsor: Acorda Therapeutics
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Sponsor: University of California, Los Angeles
Industry payments
Updated 16 Oct 2026
21 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Genentech USA, Inc.Program year202515 payments$22,725openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20253 payments$10,191openpaymentsdata.cms.gov ↗
- EMD Serono, Inc.Program year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
49.7%Gabapentinoids21.9%Gabapentin83%Pregabalin17%Part D<11 patientsPotassium Channel Blocker10.5%Dalfampridine Er100%Part D≥14 patients+ 4 more classes in this area
Cancer & immunology
30.5%Other immunostimulants13.8%Copaxone83%Glatiramer Acetate17%Part D<11 patientsPyrimidine Synthesis Inhibitor8.6%Teriflunomide59%Aubagio41%Part D<11 patients+ 3 more classes in this area
Musculoskeletal
19.8%gamma-Aminobutyric Acid-ergic Agonist15.4%Baclofen100%Part D≥35 patientsCentral alpha-2 Adrenergic Agonist2.5%Tizanidine Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis
Neurology Clinical Practice
2024 - Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
Proceedings of the National Academy of Sciences
2023 - Inflammatory Activity After Diverse Fertility Treatments
Neurology Neuroimmunology & Neuroinflammation
2023
Most-cited works
by citation count (OpenAlex)- 01Investigations of caspr2, an autoantigen of encephalitis and neuromyotoniaArticle737 citations2010
- 02Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple SclerosisArticle658 citations2006
- 03
- 04Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosisArticle366 citations2010
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/dina-jacobs-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Editorial & leadership roles
journal and society appointments- Member
American Academy of Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗ - Member
American Neurological Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗ - Member
Multiple Sclerosis International Federation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
Secondary affiliations
appointments beyond the home institution- Center for Neuroinflammation and Neurotherapeutics
Penn Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →penntoday.upenn.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
Nabila Dahodwala, MD
University of Pennsylvania
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida